论文检索
期刊
全部知识仓储预印本开放期刊机构
高级检索

Association of stage 1 hypertension defined by the 2017 ACC/AHA guideline with cardiovascular events and mortality in Chinese adultsOACSTPCD

Association of stage 1 hypertension defined by the 2017 ACC/AHA guideline with cardiovascular events and mortality in Chinese adults

英文摘要

Background:The 2017 American College of Cardiology/American Heart Association(ACC/AHA)blood pressure(BP)guideline lowered the threshold defining hypertension to 130/80 mmHg.However,how stage 1 hypertension defined using this guideline is associated with cardiovascular events in Chinese adults remains unclear.This study assessed the association between stage 1 hypertension defined by the 2017 ACC/AHA guideline and clinical outcomes in the Chinese population. Methods:Participants with stage 1 hypertension(n=69,509)or normal BP(n=34,142)were followed in this study from 2006/2007 to 2020.Stage 1 hypertension was defined as a systolic blood pressure of 130-139 mmHg or a diastolic blood pressure of 80-89 mmHg.None were taking antihypertensive medication or had a history of myocardial infarction(MI),stroke,or cancer at baseline.The primary outcome was a composite of MI,stroke,and all-cause mortality.The secondary outcomes were individual components of the primary outcome.Cox proportional hazards models were used for the analysis. Results:During a median follow-up of 11.09 years,we observed 10,479 events(MI,n=995;stroke,n=3408;all-cause mortality,n=7094).After multivariable adjustment,the hazard ratios for stage 1 hypertension vs.normal BP were 1.20(95%confidence interval[CI],1.13-1.25)for primary outcome,1.24(95%CI,1.05-1.46)for MI,1.45(95%CI,1.33-1.59)for stroke,and 1.11(95%CI,1.04-1.17)for all-cause mortality.The hazard ratios for participants with stage 1 hypertension who were prescribed antihypertensive medications compared with those without antihypertensive treatment during the follow-up was 0.90(95%CI,0.85-0.96). Conclusions:Using the new definition,Chinese adults with untreated stage 1 hypertension are at higher risk for MI,stroke,and all-cause mortality.This finding may help to validate the new BP classification system in China.

Qiannan Gao;Liuxin Li;Jingjing Bai;Luyun Fan;Jiangshan Tan;Shouling Wu;Jun Cai

Hypertension Center,Fuwai Hospital,State Key Laboratory of Cardiovascular Disease,National Center for Cardiovascular Diseases,Peking Union Medical College,Chinese Academy of Medical Sciences,Beijing 100037,ChinaDepartment of Cardiology,Kailuan General Hospital,North China University of Science and Technology,Tangshan,Hebei 063000,ChinaEmergency Center,Fuwai Hospital,State Key Laboratory of Cardiovascular Disease,National Center for Cardiovascular Diseases,Peking Union Medical College,Chinese Academy of Medical Sciences,Beijing 100037,China

Hypertension;Cardiovascular disease;All-cause mortality;Cox regression analysis

《中华医学杂志(英文版)》 2024 (001)

63-72 / 10

This work was supported by the CAMS Innovation Fund for Medical Sciences(CIFMS,No.2021-1-I2M-1-007),the National Natural Science Foundation of China(No.81825002),and the Beijing Outstanding Young Scientist Program(No.BJJWZYJH01201910023029).

10.1097/CM9.0000000000002669

评论

下载量:0
点击量:0